In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at ...

Dr Kathryn Fox is an Australian medical doctor and bestselling crime writer, best known for her forensic thrillers featuring ...

Diabetic kidney disease often develops quietly, without early warning signs. Nephrologist explains the key tests that can detect kidney damage early and help prevent serious complications.

For years, patients with C3G and IC-MPGN had few options to stop the progression toward kidney failure. Now a new class of FDA-approved C3 inhibitors that targets the root of the complement system can ...

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond ...

BUFFALO, N.Y. — For decades, pharmacists and medical institutions have relied on the Cockcroft-Gault (C-G) estimated creatinine clearance assessment to determine medication dosing and treatment for ...

Lower eGFR and higher urinary protein-to-creatinine ratio were associated with greater risks for cognitive impairment across the chronic kidney disease spectrum, according to study data published in ...

A blood test measuring levels of the protein cystatin C may provide a more reliable way to monitor for kidney problems in children and young adults with sickle cell disease (SCD), a small study ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

New research shows a simple blood test can predict the onset of Alzheimer’s symptoms, leading to earlier therapeutic care Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...